Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Krushna Chandra Hembram, Shashi Prabha, Ramesh Chandra, Bahar Ahmed & Surendra Nimesh. (2016) Advances in preparation and characterization of chitosan nanoparticles for therapeutics. Artificial Cells, Nanomedicine, and Biotechnology 44:1, pages 305-314.
Read now
Read now
Bo Qiao, Jidong Li, Qingmao Zhu, Shuquan Guo, Xiaotong Qi, Weichao Li, Jun Wu, Yang Liu & Dianming Jiang. (2014) Bone plate composed of a ternary nano-hydroxyapatite/polyamide 66/glass fiber composite: biomechanical properties and biocompatibility. International Journal of Nanomedicine 9, pages 1423-1432.
Read now
Read now
Wei-Chiao Chiu, Jyh-ming Juang, Shen-nan Chang, Cho-kai Wu, Chia-ti Tsai, Chuen-den Tseng, Yung-zu Tseng, Ming-Jai Su & Fu-tien Chiang. (2012) Differential baseline expression and angiotensin II–stimulation of leukemia-associated RhoGEF in vascular smooth muscle cells of spontaneously hypertensive rats. International Journal of Nanomedicine 7, pages 5929-5939.
Read now
Read now
Natasha F Cover, Susana Lai-Yuen, Anna K Parsons & Arun Kumar. (2012) Synergetic effects of doxycycline-loaded chitosan nanoparticles for improving drug delivery and efficacy. International Journal of Nanomedicine 7, pages 2411-2419.
Read now
Read now
Mohamad Alameh, Diogo DeJesus, Myriam Jean, Vincent Darras, Marc Thibault, Marc Lavertu, Michael D Buschmann & Abderrazzak Merzouki. (2012) Low molecular weight chitosan nanoparticulate system at low N:P ratio for nontoxic polynucleotide delivery. International Journal of Nanomedicine 7, pages 1399-1414.
Read now
Read now
Articles from other publishers (4)
Saffiya Habib, Aliscia Daniels, Mario Ariatti & Moganavelli Singh. (2021) Anti-c-myc cholesterol based lipoplexes as onco-nanotherapeutic agents in vitro. F1000Research 9, pages 770.
Crossref
Crossref
Saffiya Habib, Aliscia Daniels, Mario Ariatti & Moganavelli Singh. (2020) Anti-c-myc cholesterol based lipoplexes as onco-nanotherapeutic agents in vitro. F1000Research 9, pages 770.
Crossref
Crossref
Mohamad Alameh, Marc Lavertu, Nicolas Tran-Khanh, Chi-Yuan Chang, Frederic Lesage, Martine Bail, Vincent Darras, Anik Chevrier & Michael D. Buschmann. (2017) siRNA Delivery with Chitosan: Influence of Chitosan Molecular Weight, Degree of Deacetylation, and Amine to Phosphate Ratio on in Vitro Silencing Efficiency, Hemocompatibility, Biodistribution, and in Vivo Efficacy. Biomacromolecules 19:1, pages 112-131.
Crossref
Crossref
Myriam Jean, Mohamad Alameh, Diogo De Jesus, Marc Thibault, Marc Lavertu, Vincent Darras, Monica Nelea, Michael D. Buschmann & Abderrazzak Merzouki. (2012) Chitosan-based therapeutic nanoparticles for combination gene therapy and gene silencing of in vitro cell lines relevant to type 2 diabetes. European Journal of Pharmaceutical Sciences 45:1-2, pages 138-149.
Crossref
Crossref